Vrijwilliger Voor Marien Onderzoek
Oceanen bedekken meer dan 70% van onze planeet,...
Neuralink’s Blindsight Granted FDA Breakthrough Device Designation
Neuralink’s Blindsight Granted FDA Breakthrough Device DesignationNeuralink, a startup focusing on developing brain-computer interface (BCI) implants, has received the FDA’s breakthrough device designation for Blindsight, a high-tech experimental implant developed to restore vision to people with total loss of sight.
Blindsight is designed to send a microelectrode array into the visual cortex, the part of the brain responsible for receiving, segmenting, and integrating visual information from the retinas so that people can perceive images.
Please login to comment on this Post